Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2008-7-23
pubmed:abstractText
A low-dose protective apoptosis-mediated (PAM) process is discussed that appears to be turned on by low-dose gamma and X rays but not by low-dose alpha radiation. PAM is a bystander effect that involves cross-talk between genomically compromised [e.g., mutants, neoplastically transformed, micronucleated] cells and nongenomically compromised cells. A novel neoplastic cell transformation model, NEOTRANS(3), is discussed that includes PAM. With NEOTRANS(3), PAM is activated by low doses and inhibited by moderate or high doses and is, therefore, a hormetic process. A low-dose region of suppression of the transformation frequency below the spontaneous frequency relates to the hormetic zone over which PAM is presumed to operate. The magnitude of suppression relates to what is called the hormetic intensity. Both the hormetic intensity and width of the hormetic zone are expected to depend on dose rate, being more pronounced after low dose rates. It is expected that PAM likely had a significant role in the following observations after chronic irradiation: (1) what appears to be a tremendous reduction in the cancer incidence below the spontaneous level for Taiwanese citizens residing for years in cobalt-60 contaminated apartments; and (2) the published reductions in the lung cancer incidence below the spontaneous level in humans after protracted X irradiation and after chronic gamma plus alpha irradiation. Implications of PAM for cancer prevention and low-dose cancer therapy are briefly discussed.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/18648600-10856959, http://linkedlifedata.com/resource/pubmed/commentcorrection/18648600-10953288, http://linkedlifedata.com/resource/pubmed/commentcorrection/18648600-11205238, http://linkedlifedata.com/resource/pubmed/commentcorrection/18648600-11565407, http://linkedlifedata.com/resource/pubmed/commentcorrection/18648600-11741493, http://linkedlifedata.com/resource/pubmed/commentcorrection/18648600-12124315, http://linkedlifedata.com/resource/pubmed/commentcorrection/18648600-12195028, http://linkedlifedata.com/resource/pubmed/commentcorrection/18648600-12563110, http://linkedlifedata.com/resource/pubmed/commentcorrection/18648600-12600234, http://linkedlifedata.com/resource/pubmed/commentcorrection/18648600-12679524, http://linkedlifedata.com/resource/pubmed/commentcorrection/18648600-12851829, http://linkedlifedata.com/resource/pubmed/commentcorrection/18648600-14514653, http://linkedlifedata.com/resource/pubmed/commentcorrection/18648600-15530546, http://linkedlifedata.com/resource/pubmed/commentcorrection/18648600-15604259, http://linkedlifedata.com/resource/pubmed/commentcorrection/18648600-1704874, http://linkedlifedata.com/resource/pubmed/commentcorrection/18648600-7761580, http://linkedlifedata.com/resource/pubmed/commentcorrection/18648600-8488257, http://linkedlifedata.com/resource/pubmed/commentcorrection/18648600-8720467, http://linkedlifedata.com/resource/pubmed/commentcorrection/18648600-8927708, http://linkedlifedata.com/resource/pubmed/commentcorrection/18648600-9266965, http://linkedlifedata.com/resource/pubmed/commentcorrection/18648600-9271795, http://linkedlifedata.com/resource/pubmed/commentcorrection/18648600-9539019, http://linkedlifedata.com/resource/pubmed/commentcorrection/18648600-9652811
pubmed:language
eng
pubmed:journal
pubmed:status
PubMed-not-MEDLINE
pubmed:issn
1559-3258
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
5
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
131-49
pubmed:dateRevised
2010-6-30
pubmed:year
2007
pubmed:articleTitle
Low-dose radiation-induced protective process and implications for risk assessment, cancer prevention, and cancer therapy.
pubmed:affiliation
Lovelace Respiratory Research Institute, Albuquerque, NM, USA. bscott@LRRI.org
pubmed:publicationType
Journal Article